Centre Plans To Suspend Licences Of Drug Makers Selling Substandard Medicines

The Union Ministry of Health has proposed a <b>strict crackdown</b> on pharmaceutical companies producing drugs classified as <b>Not of Standard Quality (NSQ)</b>. Under the new guidelines, manufacturers failing to meet safety and quality parameters face the immediate <b>suspension of their licences</b> to ensure patient safety. This move aims to eliminate ineffective or harmful medicines from the supply chain, which have long plagued the healthcare sector. Citizens must remain vigilant about the quality of medicines they consume, as this policy shift seeks to hold negligent manufacturers accountable for compromising public health standards across the country.